Number of the records: 1  

New DHA derivaties and their use as medicaments

  1. 1. 0335327 - FGU-C 2010 RIV US eng P - Patent Document
    Bryhn, M. - Kopecký, Jan - Holmeide, A.K.
    New DHA derivaties and their use as medicaments.
    [Nové deriváty DHA a jejich léčebné využití.]
    Alexandria: United States Patent and Trademark Office, 2009. Owner: Pronova BioPharma Norge AS. Date of the patent registration: 04.05.2006. Date of the patent acceptance: 23.06.2009. Patent Number: US 7,550,613 B2
    R&D Projects: GA ČR(CZ) GA303/08/0664; GA MŠk(CZ) 1M0520; GA ČR(CZ) GA303/07/0708; GA MŠk(CZ) OC08007; GA MŠk(CZ) OC08008
    Institutional research plan: CEZ:AV0Z50110509
    Keywords : DHA * diabetes type 2
    Subject RIV: FB - Endocrinology, Diabetology, Metabolism, Nutrition

    New chemicals derivatives of docosahexaenoic acid have been developed. The derivatives can reduce adipose tissue inflammation and insulin resistance in mice fed high-fat diet. The derivatives could be used as medicaments to treat insulin resistance in diabetic patients

    Byly vyvinuty nové chemické deriváty kyseliny dokosahexaenové. Tyto látky potlačují zánět tukové tkáně a rezistenci k inzulinu u myší krmených vysokotukovou dietou. Tyto deriváty mohou najít uplatnění v léčbě inzulinorezistence i diabetiků
    Permanent Link: http://hdl.handle.net/11104/0179822